Videos de Experimentos Relacionados
Framingham en el 50 por ciento.
1Department of Internal Medicine, Ochsner Clinic and Alton Ochsner Medical Foundation, New Orleans, LA 70121, USA.
Lancet (London, England)
|October 6, 1998
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Urocortin 2 - a protective effect in hypertension?
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2023
Same author
In vitro fertilization exacerbates stroke size and neurological disability in wildtype mice.
International journal of cardiology·2021
Same author
Optimal blood pressure targets in 2014 - Does the guideline recommendation match the evidence base?
Hipertension y riesgo vascular·2015
Same author
Cardioprotection with beta-blockers: myths, facts and Pascal's wager.
Journal of internal medicine·2009
Same author
Beta-blockers as fourth-line therapy for hypertension: stay the course.
International journal of clinical practice·2009
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026